Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3038 |
|
| Actual shortage: | 231 (8%) | |
| Anticipated shortage: | 14 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2784 (92%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-MOXIFLOXACIN | 400MG | TABLET TABLET | Actual shortage | 2024-05-03 | 2024-05-03 | 227025 |
| APO-BRIMONIDINE-TIMOP | 0.5% 0.2% | SOLUTION | Resolved | 2024-05-03 | 2024-05-10 | 227028 |
| APO-VALACYCLOVIR | 500MG | TABLET | Actual shortage | 2024-05-03 | 2024-05-10 | 227031 |
| APO-PANTOPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Actual shortage | 2024-05-03 | 2024-05-03 | 227034 |
| APO-TERBINAFINE | 250MG | TABLET | Actual shortage | 2024-05-03 | 2024-05-03 | 227065 |
| APO-METOPROLOL (TYPE L) | 100MG | TABLET | Actual shortage | 2024-05-03 | 2024-05-03 | 227068 |
| APO-ESOMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Actual shortage | 2024-05-03 | 2024-05-03 | 227073 |
| APO-DOMPERIDONE | 10MG | TABLET | Resolved | 2024-05-03 | 2024-05-17 | 227076 |
| APO-LITHIUM CARBONATE | 300MG | CAPSULE | Actual shortage | 2024-05-03 | 2024-05-03 | 227079 |
| APO-CEFEPIME | 1G | POWDER FOR SOLUTION | Actual shortage | 2024-05-03 | 2024-05-03 | 227082 |
| APO-RIVASTIGMINE | 3MG | CAPSULE | Resolved | 2024-05-03 | 2024-05-17 | 227085 |
| APO-ATORVASTATIN | 80MG | TABLET | Actual shortage | 2024-05-03 | 2024-05-17 | 227088 |
| APO-CYCLOBENZAPRINE | 10MG | TABLET | Resolved | 2024-05-03 | 2024-05-17 | 227091 |
| APO-VALACYCLOVIR | 1000MG | TABLET | Actual shortage | 2024-05-10 | 2024-05-10 | 227714 |
| APO-SITAGLIPTIN MALATE | 25MG | TABLET | Actual shortage | 2024-05-10 | 2024-05-10 | 227717 |
| APO-ACETAMINOPHEN EXTRA STRENGTH | 500MG | TABLET | Actual shortage | 2024-05-10 | 2024-05-10 | 227722 |
| APO-ATORVASTATIN | 80MG | TABLET | Actual shortage | 2024-05-10 | 2024-05-10 | 227725 |
| APO-DOXY CAP 100MG | 100MG | CAPSULE | Actual shortage | 2024-05-10 | 2024-05-10 | 227728 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| IBUPROFEN | 200MG | TABLET | Discontinued | 2019-01-07 | 2019-07-22 | 71439 |
| IBUPROFEN CAPLETS | 400MG | TABLET | Discontinued | 2019-01-07 | 2019-07-13 | 71451 |
| APO-DILTIAZ CD | 300MG | CAPSULE (CONTROLLED-DELIVERY) | Discontinued | 2019-02-01 | 2019-02-02 | 74366 |
| APO-LOSARTAN | 25MG | TABLET | Discontinued | 2019-02-01 | 2019-02-02 | 74376 |
| APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78141 | ||
| APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78144 | ||
| APO-NEVIRAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-03-11 | 2019-03-11 | 78257 |
| APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2019-03-11 | 2019-03-11 | 78260 |
| APO-SOLIFENACIN | 10MG | TABLET | Discontinued | 2019-03-11 | 2019-09-20 | 78269 |
| APO-SOLIFENACIN | 5MG | TABLET | Discontinued | 2019-03-11 | 2019-09-20 | 78272 |
| APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83971 | ||
| APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83976 | ||
| APO-AMOXI CLAV 250MG/62.5MG PER 5ML | Discontinued | 2019-05-13 | 2019-05-13 | 83981 | ||
| APO-AMOXI CLAV | Discontinued | 2019-05-17 | 2019-05-18 | 84392 | ||
| APO-CEFPROZIL | Discontinued | 2019-05-17 | 2019-05-18 | 84396 | ||
| APO-CEFPROZIL | Discontinued | 2019-06-12 | 2019-06-12 | 86542 | ||
| APO-CIPROFLOX | Discontinued | 2019-06-12 | 2019-06-12 | 86547 | ||
| APO-EXEMESTANE | Discontinued | 2019-06-12 | 2019-06-12 | 86552 | ||
| APO-GEMFIBROZIL CAP 300MG USP | Discontinued | 2019-06-12 | 2019-06-12 | 86557 | ||
| TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |